Eisenstein, T K (2001) Implications of Salmonella-induced nitric oxide (NO) for host defense and vaccines: NO, an antimicrobial, antitumor, immunosuppressive and immunoregulatory molecule. Microbes Infect 3:1223-31
|
MacFarlane, A S; Schwacha, M G; Eisenstein, T K (1999) In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen. Infect Immun 67:891-8
|
Schwacha, M G; Meissler Jr, J J; Eisenstein, T K (1998) Salmonella typhimurium infection in mice induces nitric oxide-mediated immunosuppression through a natural killer cell-dependent pathway. Infect Immun 66:5862-6
|
Eisenstein, T K; Meissler Jr, J J; Miller, S I et al. (1998) Immunosuppression and nitric oxide production induced by parenteral live Salmonella vaccines do not correlate with protective capacity: a phoP::Tn10 mutant does not suppress but does protect. Vaccine 16:24-32
|
MacFarlane, A S; Huang, D; Schwacha, M G et al. (1998) Nitric oxide mediates immunosuppression induced by Listeria monocytogenes infection: quantitative studies. Microb Pathog 25:267-77
|
Schwacha, M G; Eisenstein, T K (1997) Interleukin-12 is critical for induction of nitric oxide-mediated immunosuppression following vaccination of mice with attenuated Salmonella typhimurium. Infect Immun 65:4897-903
|
Huang, D; Schwacha, M G; Eisenstein, T K (1996) Attenuated Salmonella vaccine-induced suppression of murine spleen cell responses to mitogen is mediated by macrophage nitric oxide: quantitative aspects. Infect Immun 64:3786-92
|
Wallace, P K; Eisenstein, T K; Meissler Jr, J J et al. (1995) Decreases in macrophage mediated antitumor activity with aging. Mech Ageing Dev 77:169-84
|
Eisenstein, T K (1994) Suppressor macrophages. Immunol Ser 60:203-24
|
Wu, L; Morahan, P S; Hendrzak, J A et al. (1994) Herpes simplex virus type 1 replication and IL-1 beta gene expression in mouse peritoneal macrophages activated in vivo by an attenuated Salmonella typhimurium vaccine or Corynebacterium parvum. Microb Pathog 16:387-99
|
Showing the most recent 10 out of 25 publications